In this respect, the design of cell-penetrating VDAC1-based peptides (Shoshan-Barmatz et al. 2015) that impair the interaction between the channel and metabolic regulators and thus impact energy homeostasis and minimize the self-defense mechanisms of cancer cells represents a novel and innovative strategy. The gene discussed is VDAC1; the disease is cancer.